Full Name: Erythropoietin
Ingredients: Recombinant glycoprotein, 165 amino acids
Appearance: White lyophilized powder, colorless and clear after dissolution
Purity: Pharmaceutical grade ≥98%
Molecular Weight: Approximately 18kDa
Storage: Store at -20℃ protected from light and sealed. After dilution, refrigerate at 2-8℃.
Usage: Subcutaneous injection / intravenous infusion. Branded versions are mostly long-acting formulations.
Stimulates bone marrow hematopoiesis, rapidly increasing red blood cells and hemoglobin, improving anemia.
Enhances blood oxygen-carrying capacity, relieving fatigue, dizziness, and shortness of breath caused by hypoxia.
Improves endurance, reducing muscle soreness and fatigue after exercise.
Improves sleep quality, relieving palpitations and insomnia caused by anemia.
Assists in postoperative and post-illness recovery, reducing transfusion dependence.
Long-lasting and stable: Branded versions have a long half-life and require less frequent dosing (e.g., once a month). (Number of doses) High purity and strong activity: stable effects, low risk in antibody preparation. Significantly improves physical condition: improved complexion, increased energy, and enhanced tolerance. Wide applicability: effective for renal anemia, post-operative recovery, high-altitude hypoxia, etc. Mature technology: strict brand quality control, minimal batch-to-batch variation, safe to use.
Actual drawbacks: Relatively high price, long-term use is costly. Requires a treatment period to take effect, typically 2-4 weeks. Significant improvement after one week.
Dosage sensitive; excessive dosage may lead to increased blood pressure and thrombosis risk.
Banned in sports; illegal use carries penalties.
A few individuals may experience headaches, low-grade fever, or discomfort at the injection site.
Chronic kidney disease, renal anemia; Post-operative, post-chemoradiotherapy/radiotherapy patients with blood and qi deficiency and anemia; Patients with chronic fatigue, pale complexion, dizziness, and shortness of breath due to anemia; Adaptation to high-altitude environments and improvement of hypoxia tolerance; Middle-aged and elderly individuals with insufficient blood and qi, lethargy, and poor sleep.
Contraindicated for those with uncontrolled hypertension, a history of thrombosis, or severe heart disease.
Strictly prohibited for pregnant women, breastfeeding mothers, and minors.
Strictly adhere to the dosage; do not increase the dosage or use frequently.
Regularly monitor hemoglobin levels to avoid excessively high levels (>12g/dL).
For conditioning/adjunctive treatment only; cannot replace regular medical care. Start with a small dose for first-time users and observe blood pressure and bodily reactions.
EPO brand version is a true "blood and qi engine," with the most direct effects on people with anemia, weakness, and hypoxia.
I have friends with kidney disease, anemia, and post-operative weakness who have used it. The most noticeable improvement was a change in their complexion from pale to rosy, a reduction in frequent dizziness and fatigue, and significant improvements in their sleep and overall well-being.
It's not a short-term stimulant; it gradually boosts hematopoietic function, making it suitable for people with long-term blood and qi deficiency, oxygen deficiency, and fatigue. However, those with unstable blood pressure or a risk of blood clots should absolutely avoid it; safety first.
Hot Tags: epo (branded) in stock, China epo (branded) in stock manufacturers, suppliers, factory
